(Q59791836)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9516667%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

title

Increased soluble interleukin 2 receptor levels in schizophrenia (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9516667%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

0 references

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9516667%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

Fergus Shanahan

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9516667%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

author name string

E O'Neill

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9516667%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

M Cole

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9516667%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

K Collins

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9516667%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

R J Daly

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9516667%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

language of work or name

English

0 references

publication date

1 February 1998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9516667%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

published in

Schizophrenia Research

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9516667%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

volume

29

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9516667%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9516667%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

page(s)

263-267

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9516667%20AND%20SRC:MED&resulttype=core&format=json

Changes in interleukin-1 beta and soluble interleukin-2 receptor levels in CSF and serum of schizophrenic patients

10 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2897%2900099-6

7 January 2021

Stimulation of oligodendroglial proliferation and maturation by interleukin-2.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2897%2900099-6

7 January 2021

Differential effect of mixed D1/D2 and selective D2 dopaminergic antagonists on mouse T and B lymphocyte proliferation and interleukin production in vitro.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2897%2900099-6

7 January 2021

Biological significance of soluble IL-2 receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2897%2900099-6

7 January 2021

The neuropsychiatric effects of treatment with interleukin-2 and lymphokine-activated killer cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2897%2900099-6

7 January 2021

The biochemistry, biology, and role of interleukin 2 in the induction of cytotoxic T cell and antibody-forming B cell responses

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2897%2900099-6

7 January 2021

Increased serum interleukin 2 receptor concentration in schizophrenic and brain-damaged subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2897%2900099-6

7 January 2021

Decreased interleukin-2 production in schizophrenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2897%2900099-6

7 January 2021

Altered interleukin-2 production in schizophrenia: association between clinical state and autoantibody production

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2897%2900099-6

7 January 2021

Abnormalities in serum concentrations of interleukin-2, interferon-alpha and interferon-gamma in schizophrenia not detected

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2897%2900099-6

7 January 2021

Psychological stress-induced modulation of interleukin 2 receptor gene expression and interleukin 2 production in peripheral blood leukocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2897%2900099-6

7 January 2021

Modulation of hippocampal acetylcholine release: a potent central action of interleukin-2.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2897%2900099-6

7 January 2021

Can autoimmune mechanisms account for the genetic predisposition to schizophrenia?

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2897%2900099-6

7 January 2021

A role for interleukin-2 in the regulation of striatal dopaminergic function

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2897%2900099-6

7 January 2021

Elevated central levels of interleukin-2 in drug-free schizophrenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2897%2900099-6

7 January 2021

Increases in CSF levels of interleukin-2 in schizophrenia: effects of recurrence of psychosis and medication status

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2897%2900099-6

7 January 2021

Immune-inflammatory markers in schizophrenia: comparison to normal controls and effects of clozapine

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2897%2900099-6

7 January 2021

Plasma soluble interleukin-2-receptor in depression: relationships to plasma neopterin and serum IL-2 concentrations and HPA-axis activity

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2897%2900099-6

7 January 2021

Plasma-soluble interleukin-2 and transferrin receptor in schizoprenia and major depression

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2897%2900099-6

7 January 2021

Interleukin-2 modulates calcium currents in dissociated hippocampal CA1 neurons.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2897%2900099-6

7 January 2021

Clozapine-induced increase in plasma levels of soluble interleukin-2 receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2897%2900099-6

7 January 2021

Elevated levels of soluble interleukin 2 receptors in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2897%2900099-6

7 January 2021

The effects of typical and atypical neuroleptics on mitogen-induced T lymphocyte responsiveness

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2897%2900099-6

7 January 2021

Haloperidol and soluble interleukin-2 receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2897%2900099-6

7 January 2021

Increased serum soluble interleukin-2 receptors in schizophrenic monozygotic twins

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2897%2900099-6

7 January 2021

Increased serum soluble interleukin-2 receptors in Caucasian and Korean schizophrenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2897%2900099-6

7 January 2021

Interleukin-2 promotes survival and neurite extension of cultured neurons from fetal rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2897%2900099-6

7 January 2021

Inhibition by chlorpromazine of lymphokine-specific mRNA expression in human thymocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2897%2900099-6

7 January 2021

Schizophrenia Following Pre-natal Exposure to Influenza Epidemics Between 1939 and 1960

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2897%2900099-6

7 January 2021

https://api.crossref.org/works/10.1016%2FS0920-9964%2897%2900099-6

1 reference

7 January 2021

Decreased production of interleukin-2 in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2897%2900099-6

7 January 2021

Aberrant T cell-mediated immunity in untreated schizophrenic patients: deficient interleukin-2 production

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2897%2900099-6

7 January 2021

Schizophrenia: genetics and the maternal immune response to viral infection

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2897%2900099-6

7 January 2021

Changes of plasma concentrations of interleukin-1 alpha and interleukin-6 with neuroleptic treatment for schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2897%2900099-6

7 January 2021

10.1016/S0920-9964(97)00099-6

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9516667%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

1 reference